American Gene Technologies (AGT) Moves HQ to New Facility, Expands Lab Space for HIV and Cancer Cure Research

by NASDAQ Market News July 28, 2020

NASDAQ Market News
Click here to email author

Orion’s phase 3 REFALS trial evaluating the efficacy of oral levosimendan in treatment of ALS patients did not reach its pre-specified endpoints

Basilea announces completion of its transaction involving a partial repurchase of its existing bond and the issuance of a new bond

Ads